CV Science

Anne Astier PhD Immunology

Course and current status

Current position:

2021 - CNRS DR2 - Infinity au sein de l’équipe 4“Maladies inflammatoires du système nerveux central” dirigée par Pr R Liblau and Dr A Saoudi. Thématique: “T cell regulation and role of environmental factors in chronic inflammation”.

2017 - CNRS CRCN - Centre de Physiopathologie Toulouse-Purpan au sein de l’équipe 5 “Maladies inflammatoires du système nerveux central” dirigée par Pr R Liblau and Dr A Saoudi. Thématique: “T cell regulation and role of environmental factors in chronic inflammation”.

2017 - Associate member, Edinburgh Centre for MS Research / MRC Centre for Inflammation Research, University of Edinburgh, UK

Previous positions:

2011 - 2017    MRC Academic Research fellow, group leader, University of Edinburgh/MRC Centre for Inflammation Research, Edinburgh Centre for MS Research. Environmental factors in chronic inflammatory diseases.

2007- 2010     Research fellow, group leader, University of Edinburgh, Institute for Immunology and Infection Research/Centre for Inflammation Research. T cell activation in MS.

2005-2007      Faculty member, Instructor in Neurology, Harvard Medical School. Brigham and Women’s Hospital, Boston MA. T cell activation in MS.

2005-2007      Member of the Broad Institute of Harvard and MIT, Cambridge, MA, USA. RNAi Platform - 1^st large RNAi screen in primary T cells.

2004-2005      Research fellow, Harvard Medical School. Center for Neurological Diseases, Brigham and Women’s Hospital, Boston MA. T cell activation in MS.

2001-2004      Visiting Research fellow, in the Dept of Medical Oncology, Haematologic Malignancies division, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. B cell activation in lymphomas.                                                           

1997-              CNRS (Chargée de Recherche CR2 (CR1 en 2001) – INSERM U503, Lyon, France. (2002: “détachement”). CD46 in human T cell activation.

1994-1998      Postdoctoral Research fellow in Haematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. B cell activation in lymphomas.

1990-1994  PhD  - Characterization of soluble FcgRII receptors – Institut Curie / Université Paris VI, (head: WH Fridman; thesis supervisor: Jean-Luc Teillaud

Scientific summary